Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells

Blood

Volumn 87, Issue 4, 1996, Pages 1225-1231

  Aguila, Héctor L ^a,b   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GRAFT REJECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HLA SYSTEM; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030022214     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1225.bloodjournal8741225     Document Type: Article

References (47)

1. + hematopoietic stem cell. Blood 83:3758, 1994
2. Bennett M: Rejection of marrow allografts. Importance of H-2 homozygosity of donor cells. Transplantation 14:289, 1972
3. Storb R, Thomas ED: Allogeneic bone marrow transplantation. Immunol Rev 71:77, 1983
4. Prentice HG, Blacklock HA, Janossy G, Bradstock KF, Skeggs D, Goldstein G: Use of anti-T-cell monoclonal antibody OKT3 to prevent graft-versus-host disease in allogeneic bone marrow transplantation for acute leukemia. Lancet 1:700, 1982
5. Vallera DA, Soderling CCB, Carlson GJ, Kersey JH: Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy1.2 plus complement or antibody alone. Transplantation 31:218, 1981
6. Shizuru JA, Jerabek L, Edwards CT, Weissman IL: Transplantation of purified hematopoietic stem cells: Requirements for overcoming the barriers of allogeneic engraftment. Biol Blood Marrow Transplant (in press)
7. Martin PJ, Hansen JA, Storb R, Thomas ED: Human bone marrow transplantation: An immunological perspective. Adv Immunol 40:379, 1987
8. Bennett M: Biology and genetics of hybrid resistance. Adv Immunol 41:333, 1987
9. Cudkowicz G, Hochman PS: Do natural killer cells engage in regulated reactions against self to ensure homeostasis? Immunol Rev 44:13, 1979
10. Ljunggren H-G, Karre K: In search of the "missing self": MHC molecules and NK recognition. Immunol Today 11:237, 1990
11. Bennett M, Rembecki RM, Sentman CL, Murphy WJ, Yu YYL, Davenport C, Kumar V: Bone marrow transplantation and natural killer cells in mice, in Rolstad B (ed): Natural Immunity to Normal Hemopoietic Cells. Ann Arbor, MI, CRC, 1994, p 33
12. Murphy WJ, Kumar V, Bennett M: Rejection of bone marrow allografts by mice with severe combined immune deficiency (scid). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 165:1212, 1987
13. Lotzova E, Savary CA, Pollack SB: Prevention of rejection of allogeneic bone marrow transplants by NK1.1 antiserum. Transplantation 35:490, 1983
14. Tiberghien P, Longo DL, Wine JW, Alvord WD, Reynolds CW: Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: Evidence that recipient natural killer depletion enhances survival, engraftment and hematopoietic recovery. Blood 76:1419, 1990
15. f. Eur J Immunol 21:2821, 1991
16. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187, 1989
17. Yu YYL, Kumar V, Bennett M: Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 10:189, 1992
18. Yokoyama WM: Review. Natural killer cell receptors specific for major histocompatibiliy class I molecules Proc Natl Acad Sci USA 92:3081, 1995
19. Bezouska K, Yuen C-T, O'Brien J, Childs RA, Chai W, Lawson AM, Drbal K, Fiserová A, Pospísil M, Feizi T: High affinity oligosaccharide ligands for NKR-P1 protein that elicits natural killer cell activation and cytotoxicity. Nature 372:150, 1994
20. Ryan JC, Niemi EC, Nakamura MC, Seaman WE: NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J Exp Med 181:1911, 1995
21. Karlhofer FM, Ribaudo RK, Yokoyama WM: MHC class I alloantigen specificity of Ly-49 + IL-2 activated natural killer cells. Nature 358:66, 1992
22. Mason LH, Ortaldo JR, Young HA, Kumar V, Bennett M, Anderson SK: Cloning and functional characteristics of murine large granular lymphocyte-1: A member of the Ly-49 gene family (Ly-49G2). J Exp Med 182:293, 1995
23. Stoneman ER, Bennett M, An J, Chesnut KA, Wakeland EK, Scheerer JB, Siciliano MJ, Kumar V, Mathhew PA: Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med 182:305, 1995
24. Daniels BF, Karlhofer FM, Seaman WE, Yokoyama WM: A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med 180:687, 1994
25. Karlhofer FM, Hunziker R, Reichlin A, Margulies DH, Yokoyama WM: Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J Immunol 153:2407, 1994
26. b bone marrow grafts. J Exp Med 170:191, 1989
27. Aguila HL, Hershberger RJ, Weissman IL: Transgenic mice carrying the diphtheria toxin A chain gene under the control of the granzyme A promoter: Expected depletion of cytotoxic cells and unexpected depletion of CD8 T cells. Proc Natl Acad Sci USA 92:10192, 1995
28. Park DR, Herzenberg LA: Fluorescence-activated cell sorting: Theory, experimental optimizations, and applications in lymphoid cell biology. Methods Enzymol 108:197, 1984
29. French D, Kelly T, Buhl B, Scharff MD: Somatic cell genetic analysis of myelomas and hybridomas. Methods Enzymol 151:50, 1987
30. 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181, 1968
31. Spangrude GJ, Heimfeld S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988
32. Smith LG, Weissman IL, Heimfeld S: Clonal analysis of hematopoieic stem-cell differentiation in vivo. Proc Natl Acad Sci USA 88:2788, 1990
33. Uchida N, Fleming WH, Alpern EJ, Weissman IL: Heterogeneity of hematopoietic stem cells. Curr Opin Immunol 5:177, 1993
34. Ogasawara J, Watanabe-Fukunage R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-fas antibody in mice. Nature 364:806, 1993
35. Kagi D, Ledermann B, Bürki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31, 1994
36. Shresta S, MacIvor DM, Heusel JW, Russell JH, Ley TJ: Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in suceptible target cells. Proc Natl Acad Sci USA 92:5679, 1995
37. Baker MB, Podack ER, Levy RB: Perform and fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice. Biol Blood Marrow Transplant 1:69, 1995
38. 37a. Graubert TA, Russell JH, Ley TJ: The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 87:1232, 1996
39. Degliatoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G: Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. J Exp Med 162:1512, 1985
40. Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV, Palldino MA: Natural killer-sensitive targets stimulate production of TNF-a but not TNF-b (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol 137:2592, 1986
41. Handa K, Suzuki R, Matsui H, Shimizu Y, Kumagai K: Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon γ production. J Immunol 130:988, 1983
42. Bancroft GJ, Schreiber RD, Unanue ER: Natural immunity: A T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev 124:5, 1992
43. Scala G, Allavena P, Djeu JY, Kasahara T, Ortaldo JR, Herberman RB, Oppenheim JJ: Human large granular lymphocytes are potent producers of interleukin-1. Nature 309.56, 1984
44. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
45. Zhang Y, Harada A, Bluethmann H, Wang J-B, Nakao S, Mukaida N, Matsushima K: Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: Increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNFα in vitro. Blood 86:2930, 1995
46. Tartaglia LA, Rothe M, Hu YF, Goeddel DV: Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73:213, 1993
47. Berke G: The CTL's kiss of death. Cell 81:9, 1995